Nanoparticle Delivery of Delamanid for Cost-effective Treatment of Tuberculosis, Satya K Nayagam, UG '22 (2310833)Tuberculosis remains a major health issue in the world today with over 10 million cases a year. Delamanid (Deltyba) is a new drug for the treatment of multidrug-resistant TB that was approved in…
From Research Princeton Research Day
4
4 likes
| 148
148 plays
|
|
Dean for Research Award for Distinguished Innovation: Honorary Lecture by Professor Robert K. Prud'hommeThis session was part of Engage 2020, the new Princeton University innovation and entrepreneurship conference. During Engage 2020, Professor Robert Prud’homme delivered a lecture on his…
From Innovation Innovation Communication
0
0 likes
| 22
22 plays
|
© 2022 The Trustees of Princeton University
Broadcast Center | 1E12 Green Hall | Princeton, NJ 08544 | 609.258.7872 | [email protected]